These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8527732)

  • 1. Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease.
    Qureshi GA; Baig S; Bednar I; Södersten P; Forsberg G; Siden A
    Neuroreport; 1995 Aug; 6(12):1642-4. PubMed ID: 8527732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases.
    Ikeda M; Sato I; Yuasa T; Miyatake T; Murota S
    J Neural Transm Gen Sect; 1995; 100(3):263-7. PubMed ID: 8748672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease.
    Shukla R; Rajani M; Srivastava N; Barthwal MK; Dikshit M
    Int J Neurosci; 2006 Dec; 116(12):1391-402. PubMed ID: 17145675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients.
    Kuiper MA; Teerlink T; Visser JJ; Bergmans PL; Scheltens P; Wolters EC
    J Neural Transm (Vienna); 2000; 107(2):183-9. PubMed ID: 10847559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients.
    Kuiper MA; Visser JJ; Bergmans PL; Scheltens P; Wolters EC
    J Neurol Sci; 1994 Jan; 121(1):46-9. PubMed ID: 8133311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
    Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Hamato H
    Neurosci Lett; 1993 Sep; 159(1-2):135-8. PubMed ID: 7505410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Jung CS; Oldfield EH; Harvey-White J; Espey MG; Zimmermann M; Seifert V; Pluta RM
    J Neurosurg; 2007 Nov; 107(5):945-50. PubMed ID: 17977265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage.
    Martens-Lobenhoffer J; Sulyok E; Czeiter E; Büki A; Kohl J; Firsching R; Tröger U; Bode-Böger SM
    J Neurosci Methods; 2007 Aug; 164(1):155-60. PubMed ID: 17512604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine sulfate in ventricular cerebrospinal fluid and motor function in Parkinson's disease.
    Cedarbaum JM; Olanow CW
    Neurology; 1991 Oct; 41(10):1567-70. PubMed ID: 1922797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nitric oxide in bacterial meningitis in children.
    Kornelisse RF; Hoekman K; Visser JJ; Hop WC; Huijmans JG; van der Straaten PJ; van der Heijden AJ; Sukhai RN; Neijens HJ; de Groot R
    J Infect Dis; 1996 Jul; 174(1):120-6. PubMed ID: 8655981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
    Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
    J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphonuclear leukocyte nitrite content and antioxidant enzymes in Parkinson's disease patients.
    Barthwal MK; Srivastava N; Shukla R; Nag D; Seth PK; Srimal RC; Dikshit M
    Acta Neurol Scand; 1999 Nov; 100(5):300-4. PubMed ID: 10536916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid nitrate levels in patients with Parkinson's disease.
    Molina JA; Jiménez-Jiménez FJ; Navarro JA; Vargas C; Gómez P; Benito-León J; Ortí-Pareja M; Cisneros E; Arenas J
    Acta Neurol Scand; 1996; 93(2-3):123-6. PubMed ID: 8741130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid choline levels are decreased in Parkinson's disease.
    Manyam BV; Giacobini E; Colliver JA
    Ann Neurol; 1990 Jun; 27(6):683-5. PubMed ID: 2360805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid and plasma nitrite and nitrate concentrations after head injury in humans.
    Clark RS; Kochanek PM; Obrist WD; Wong HR; Billiar TR; Wisniewski SR; Marion DW
    Crit Care Med; 1996 Jul; 24(7):1243-51. PubMed ID: 8674343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson's disease.
    Isobe C; Abe T; Kikuchi T; Murata T; Sato C; Terayama Y
    Eur J Neurol; 2006 Apr; 13(4):346-50. PubMed ID: 16643311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson's disease.
    Isobe C; Abe T; Terayama Y
    J Clin Neurosci; 2010 Jun; 17(6):717-21. PubMed ID: 20356746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies.
    Molina JA; Leza JC; Ortiz S; Moro MA; Pérez S; Lizasoaín I; Urigüen L; Oliva JM; Manzanares J
    Neurosci Lett; 2002 Nov; 333(2):151-3. PubMed ID: 12419502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.